Journal of Jilin University(Medicine Edition) ›› 2022, Vol. 48 ›› Issue (2): 493-499.doi: 10.13481/j.1671-587X.20220228

• Clinical medicine • Previous Articles     Next Articles

Effect of guided biofilm therapy for periodontitis in diabetic patient: A case report and literature review

Peipei ZHANG,Donghui GAO,Yue TIAN,Hongyan LI()   

  1. Department of Periodontology,Stomatology Hospital,Jilin University,Changchun 130021,China
  • Received:2021-07-09 Online:2022-03-28 Published:2022-05-10
  • Contact: Hongyan LI E-mail:lihongy99@jlu.edu.cn

Abstract: Objective

To analyze the role of guided biofilm therapy (GBT) in the therapy of the patient with periodontitis and diabetes mellitus, and to provide the basis for the diagnosis and treatment of periodontitis associated with systemic diseases.

Methods

The clinical materials of one periodontitis patient with type 2 diabetes mellitus (T2DM) were collected, and GBT was performed. The positive rates of bleeding on probing(BOP), probing depth (PD), attachment loss (AL), the number of deep periodontal pockets (>5 mm), and the levels of fasting blood glucose and glycated hemoglobin (HbA1c) of the patient were examined and recorded at the first visit, 1 month, 3 months, 6 months, 1 year and 2 years after GBT, respectively. The related literatures were reviewed.

Results

After GBT,the positive rates of BOP, PD, AL, the number of deep periodontal pockets, and the levels of fasting blood glucose and HbA1c were decreased in varying degrees. Two years after treatment, there was no obvious gingival inflammation in the whole mouth, the positive rate of BOP was 10%,the average PD value was 2.18 mm, the AL was reduced to 0.98 mm, the positive rate of plaque was 20%, and there was no deep periodontal pocket greater than 5 mm. The fasting blood glucose was 5.5 mmol·L-1, and the HbA1c was 5.9%.

Conclusion

GBT is more effective in the treatment of periodontitis associated with T2DM, and it is beneficial for the long-term control of blood glucose.

Key words: Guided biofilm therapy, Diabetes mellitus,type 2, Periodontitis, Initial periodontal therapy

CLC Number: 

  • R781